Global Central Nervous System (CNS) Stimulant Drugs Market 2025-2029

Central Nervous System (CNS) Stimulant Drugs Market 2025-2029

The central nervous system (CNS) stimulant drugs market is forecasted to grow by USD 8600.1 million during 2024-2029, accelerating at a CAGR of 6.7% during the forecast period. The report on the central nervous system (CNS) stimulant drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by approval of new stimulants, growing research and development, and increasing clinical trials by companies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's central nervous system (CNS) stimulant drugs market is segmented as below:

By Distribution Channel

  • Hospitals
  • Others
By Application
  • Attention-deficit hyperactivity disorder
  • Narcolepsy
  • Others
By Route Of Administration
  • Oral tablets and capsules
  • Injectables
  • Transdermal patches
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increased uptake of new-generation drugs as one of the prime reasons driving the central nervous system (CNS) stimulant drugs market growth during the next few years. Also, rising demand to legalize cannabis worldwide and increasing repurposing of drugs will lead to sizable demand in the market.

The report on the central nervous system (CNS) stimulant drugs market covers the following areas:
  • Central Nervous System (CNS) Stimulant Drugs Market sizing
  • Central Nervous System (CNS) Stimulant Drugs Market forecast
  • Central Nervous System (CNS) Stimulant Drugs Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading central nervous system (CNS) stimulant drugs market vendors that include Astellas Pharma Inc., Azurity Pharmaceuticals Inc., Elite Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Ironshore, Jazz Pharmaceuticals PLC, KemPharm Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, Sanofi SA, SHIONOGI Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., Tris Pharma Inc., and Viatris Inc.. Also, the central nervous system (CNS) stimulant drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Central Nervous System (CNS) Stimulant Drugs Market 2019 - 2023
Historic Market Size - Data Table on Global Central Nervous System (CNS) Stimulant Drugs Market 2019 - 2023 ($ million)
5.2 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.3 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.4 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on the Global Central Nervous System (CNS) Stimulant Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Distribution Channel
8.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
8.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
8.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
8.4 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Application
9.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
9.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
9.3 Attention-deficit hyperactivity disorder - Market size and forecast 2024-2029
Chart on Attention-deficit hyperactivity disorder - Market size and forecast 2024-2029 ($ million)
Data Table on Attention-deficit hyperactivity disorder - Market size and forecast 2024-2029 ($ million)
Chart on Attention-deficit hyperactivity disorder - Year-over-year growth 2024-2029 (%)
Data Table on Attention-deficit hyperactivity disorder - Year-over-year growth 2024-2029 (%)
9.4 Narcolepsy - Market size and forecast 2024-2029
Chart on Narcolepsy - Market size and forecast 2024-2029 ($ million)
Data Table on Narcolepsy - Market size and forecast 2024-2029 ($ million)
Chart on Narcolepsy - Year-over-year growth 2024-2029 (%)
Data Table on Narcolepsy - Year-over-year growth 2024-2029 (%)
9.5 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
10.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
10.3 Oral tablets and capsules - Market size and forecast 2024-2029
Chart on Oral tablets and capsules - Market size and forecast 2024-2029 ($ million)
Data Table on Oral tablets and capsules - Market size and forecast 2024-2029 ($ million)
Chart on Oral tablets and capsules - Year-over-year growth 2024-2029 (%)
Data Table on Oral tablets and capsules - Year-over-year growth 2024-2029 (%)
10.4 Injectables - Market size and forecast 2024-2029
Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Chart on Injectables - Year-over-year growth 2024-2029 (%)
Data Table on Injectables - Year-over-year growth 2024-2029 (%)
10.5 Transdermal patches - Market size and forecast 2024-2029
Chart on Transdermal patches - Market size and forecast 2024-2029 ($ million)
Data Table on Transdermal patches - Market size and forecast 2024-2029 ($ million)
Chart on Transdermal patches - Year-over-year growth 2024-2029 (%)
Data Table on Transdermal patches - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.11 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.12 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Azurity Pharmaceuticals Inc.
Azurity Pharmaceuticals Inc. - Overview
Azurity Pharmaceuticals Inc. - Product / Service
Azurity Pharmaceuticals Inc. - Key offerings
SWOT
15.5 Elite Pharmaceuticals Inc.
Elite Pharmaceuticals Inc. - Overview
Elite Pharmaceuticals Inc. - Product / Service
Elite Pharmaceuticals Inc. - Key offerings
SWOT
15.6 Hisamitsu Pharmaceutical Co. Inc.
Hisamitsu Pharmaceutical Co. Inc. - Overview
Hisamitsu Pharmaceutical Co. Inc. - Key offerings
SWOT
15.7 Ironshore
Ironshore - Overview
Ironshore - Product / Service
Ironshore - Key offerings
SWOT
15.8 Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc - Overview
Jazz Pharmaceuticals Plc - Product / Service
Jazz Pharmaceuticals Plc - Key news
Jazz Pharmaceuticals Plc - Key offerings
SWOT
15.9 KemPharm Inc.
KemPharm Inc. - Overview
KemPharm Inc. - Key offerings
SWOT
15.10 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
15.11 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.12 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.13 Purdue Pharma LP
Purdue Pharma LP - Overview
Purdue Pharma LP - Product / Service
Purdue Pharma LP - Key offerings
SWOT
15.14 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15.15 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
SWOT
15.16 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
15.17 Tris Pharma Inc.
Tris Pharma Inc. - Overview
Tris Pharma Inc. - Product / Service
Tris Pharma Inc. - Key offerings
SWOT
15.18 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Central Nervous System (CNS) Stimulant Drugs Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits39: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Distribution Channel
Exhibits41: Data Table on Comparison by Distribution Channel
Exhibits42: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits50: Market opportunity by Distribution Channel ($ million)
Exhibits51: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits52: Chart on Application - Market share 2024-2029 (%)
Exhibits53: Data Table on Application - Market share 2024-2029 (%)
Exhibits54: Chart on Comparison by Application
Exhibits55: Data Table on Comparison by Application
Exhibits56: Chart on Attention-deficit hyperactivity disorder - Market size and forecast 2024-2029 ($ million)
Exhibits57: Data Table on Attention-deficit hyperactivity disorder - Market size and forecast 2024-2029 ($ million)
Exhibits58: Chart on Attention-deficit hyperactivity disorder - Year-over-year growth 2024-2029 (%)
Exhibits59: Data Table on Attention-deficit hyperactivity disorder - Year-over-year growth 2024-2029 (%)
Exhibits60: Chart on Narcolepsy - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Narcolepsy - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Narcolepsy - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Narcolepsy - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits68: Market opportunity by Application ($ million)
Exhibits69: Data Table on Market opportunity by Application ($ million)
Exhibits70: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits71: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits72: Chart on Comparison by Route of Administration
Exhibits73: Data Table on Comparison by Route of Administration
Exhibits74: Chart on Oral tablets and capsules - Market size and forecast 2024-2029 ($ million)
Exhibits75: Data Table on Oral tablets and capsules - Market size and forecast 2024-2029 ($ million)
Exhibits76: Chart on Oral tablets and capsules - Year-over-year growth 2024-2029 (%)
Exhibits77: Data Table on Oral tablets and capsules - Year-over-year growth 2024-2029 (%)
Exhibits78: Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits79: Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits80: Chart on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits82: Chart on Transdermal patches - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Transdermal patches - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Transdermal patches - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Transdermal patches - Year-over-year growth 2024-2029 (%)
Exhibits86: Market opportunity by Route of Administration ($ million)
Exhibits87: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits89: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits90: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits91: Chart on Geographic comparison
Exhibits92: Data Table on Geographic comparison
Exhibits93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits149: Market opportunity By Geographical Landscape ($ million)
Exhibits150: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits151: Impact of drivers and challenges in 2024 and 2029
Exhibits152: Overview on criticality of inputs and factors of differentiation
Exhibits153: Overview on factors of disruption
Exhibits154: Impact of key risks on business
Exhibits155: Companies covered
Exhibits156: Company ranking index
Exhibits157: Matrix on companies position and classification
Exhibits158: Azurity Pharmaceuticals Inc. - Overview
Exhibits159: Azurity Pharmaceuticals Inc. - Product / Service
Exhibits160: Azurity Pharmaceuticals Inc. - Key offerings
Exhibits161: SWOT
Exhibits162: Elite Pharmaceuticals Inc. - Overview
Exhibits163: Elite Pharmaceuticals Inc. - Product / Service
Exhibits164: Elite Pharmaceuticals Inc. - Key offerings
Exhibits165: SWOT
Exhibits166: Hisamitsu Pharmaceutical Co. Inc. - Overview
Exhibits167: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
Exhibits168: SWOT
Exhibits169: Ironshore - Overview
Exhibits170: Ironshore - Product / Service
Exhibits171: Ironshore - Key offerings
Exhibits172: SWOT
Exhibits173: Jazz Pharmaceuticals Plc - Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings